Massachusetts General Hosptial

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Multiple myeloma2 trials
• Metastatic breast cancer1 trial

Phase

• Phase 22 trials
• Phase 11 trial

Status

• Active, not recruiting2 trials
• Completed1 trial

Lead sponsor

• Beth Israel Deaconess Medical Center1 trial
• Dana-Farber Cancer Institute1 trial
• Massachusetts General Hospital1 trial

Running trials

• Active, not recruiting

  Sotatercept (ACE-011) With Lenalidomide or Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma

  NCT01562405· Phase 1· Massachusetts General Hospital· Source

• Active, not recruiting

  Efficacy and Safety of 500mg of Fulvestrant

  NCT00585507· Phase 2· Beth Israel Deaconess Medical Center· Source

Closed trials

• Completed

  Phase II Study of Efficacy and Safety of Lenalidomide, Subcutaneous Bortezomib and Dexamethasone Therapy for Newly Diagnosed Multiple Myeloma

  NCT02441686· Phase 2· Dana-Farber Cancer Institute· Source